Fluorescent estimation on the effect of Ca2+ antagonists on the oxidative metabolism in dissociated mammalian brain

Y Oyama1, A Hayashi, T Ueha

  • 1Division of Pharmacological Science, Faculty of Integrated Arts and Sciences, University of Tokushima, Japan.

Brain Research
|April 30, 1993
PubMed

Insights

Organic calcium (Ca2+) antagonists like flunarizine and nifedipine reduce reactive oxygen species formation in neurons. This suggests a protective mechanism against ischemic brain damage by these specific drugs.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Oxidative stress and reactive oxygen species (ROS) play a critical role in neuronal damage, particularly during ischemic events.
  • Calcium (Ca2+) influx is implicated in the pathophysiology of ischemic brain injury.
  • Organic Ca2+ antagonists are a class of drugs used to manage various cardiovascular and neurological conditions.

Purpose of the Study:

  • To investigate the effect of organic calcium (Ca2+) antagonists on oxidative metabolism and reactive oxygen species (ROS) generation in mammalian neurons.
  • To determine if specific Ca2+ antagonists exhibit neuroprotective properties by modulating cellular oxidant levels.

Main Methods:

  • Utilized dissociated mammalian neurons for experimental analysis.
  • Employed flow cytometry to quantify cellular oxidative metabolism.
  • Used 2',7'-dichlorofluorescin (DCFH) as a fluorescent indicator for cellular oxidants, as it is oxidized to a fluorescent compound by ROS.

Main Results:

  • Flunarizine and nifedipine demonstrated a significant decrease in 2',7'-dichlorofluorescin (DCFH) fluorescence intensity at concentrations of 1 microM or higher.
  • Verapamil and diltiazem did not exhibit a similar reduction in DCFH fluorescence under the tested conditions.
  • The observed reduction in fluorescence by flunarizine and nifedipine indicates a decrease in reactive oxygen species (ROS) formation.

Conclusions:

  • Flunarizine and nifedipine possess the ability to reduce oxidative stress in neurons by inhibiting reactive oxygen species (ROS) production.
  • These findings suggest a potential favorable mechanism of action for flunarizine and nifedipine in mitigating ischemic brain damage.
  • The differential effects among organic Ca2+ antagonists highlight the need for specific drug evaluation in the context of neuroprotection.

Related Concept Videos